Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases

Author:

Fitzek Antonia,Schädler Julia,Dietz Eric,Ron Alexandra,Gerling Moritz,Kammal Anna L.,Lohner Larissa,Falck Carla,Möbius Dustin,Goebels Hanna,Gerberding Anna-Lina,Schröder Ann Sophie,Sperhake Jan-Peter,Klein Anke,Fröb Daniela,Mushumba Herbert,Wilmes Sandra,Anders Sven,Kniep Inga,Heinrich Fabian,Langenwalder Felicia,Meißner Kira,Lange Philine,Zapf Antonia,Püschel Klaus,Heinemann Axel,Glatzel Markus,Matschke Jakob,Aepfelbacher Martin,Lütgehetmann Marc,Steurer Stefan,Thorns Christoph,Edler Carolin,Ondruschka Benjamin

Abstract

AbstractCoronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic with significant mortality. Accurate information on the specific circumstances of death and whether patients died from or with SARS-CoV-2 is scarce. To distinguish COVID-19 from non-COVID-19 deaths, we performed a systematic review of 735 SARS-CoV-2-associated deaths in Hamburg, Germany, from March to December 2020, using conventional autopsy, ultrasound-guided minimally invasive autopsy, postmortem computed tomography and medical records. Statistical analyses including multiple logistic regression were used to compare both cohorts. 84.1% (n = 618) were classified as COVID-19 deaths, 6.4% (n = 47) as non-COVID-19 deaths, 9.5% (n = 70) remained unclear. Median age of COVID-19 deaths was 83.0 years, 54.4% were male. In the autopsy group (n = 283), the majority died of pneumonia and/or diffuse alveolar damage (73.6%; n = 187). Thromboses were found in 39.2% (n = 62/158 cases), pulmonary embolism in 22.1% (n = 56/253 cases). In 2020, annual mortality in Hamburg was about 5.5% higher than in the previous 20 years, of which 3.4% (n = 618) represented COVID-19 deaths. Our study highlights the need for mortality surveillance and postmortem examinations. The vast majority of individuals who died directly from SARS-CoV-2 infection were of advanced age and had multiple comorbidities.

Funder

German Federal Ministry of Education and Research

Authorities for Social Welfare, Hamburg, Germany

Universitätsklinikum Hamburg-Eppendorf (UKE)

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference59 articles.

1. Zhu, N. et al. A novel coronavirus from patients with pneumonia in China. N. Engl. J. Med. 382(8), 727–733 (2020).

2. World Health Organization. WHO Director-General's Opening Remarks at the Media Briefing on COVID-19 https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020).

3. Johns Hopkins University. Coronavirus Resource Center. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) https://coronavirus.jhu.edu/map.html (2021).

4. World Health Organization. WHO Coronavirus (COVID-19) Dashboard https://covid19.who.int/ (2021).

5. Robert Koch Institut. Empfehlungen zum Umgang mit SARS-CoV-2-infizierten Verstorbenen https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Verstorbene.html (2021).

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3